SHILPAMED.NSSHILPAMED.NSNSE
Loading
Year-over-year gross profit growth rate
Percentile
P10
Near historical low
vs 3Y Ago
-5.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -38.52% |
| Q3 2025 | 9.35% |
| Q2 2025 | 6.86% |
| Q1 2025 | -0.87% |
| Q4 2024 | 2.93% |
| Q3 2024 | 120.81% |
| Q2 2024 | -0.58% |
| Q1 2024 | -46.81% |
| Q4 2023 | 1.48% |
| Q3 2023 | 157.56% |
| Q2 2023 | -43.92% |
| Q1 2023 | -17.44% |
| Q4 2022 | 7.18% |
| Q3 2022 | -6.83% |
| Q2 2022 | 19.76% |
| Q1 2022 | -27.43% |
| Q4 2021 | -6.28% |
| Q3 2021 | 19.58% |
| Q2 2021 | -3.77% |
| Q1 2021 | 31.31% |
| Q4 2020 | -27.13% |
| Q3 2020 | 10.47% |
| Q2 2020 | 82.62% |
| Q1 2020 | -49.81% |
| Q4 2019 | -12.46% |
| Q3 2019 | 296.37% |
| Q2 2019 | -60.10% |
| Q1 2019 | 16.51% |
| Q4 2018 | -8.36% |
| Q3 2018 | -8.26% |
| Q2 2018 | 72.46% |
| Q1 2018 | -21.40% |
| Q4 2017 | -21.23% |
| Q3 2017 | 30.52% |
| Q2 2017 | -29.29% |
| Q1 2017 | 35.92% |
| Q4 2016 | -6.23% |
| Q3 2016 | 25.58% |
| Q2 2016 | -12.01% |
| Q1 2016 | 3.27% |